Gender-Related Differences in the Practices and Attitudes of Early Detection in Rumanian Skin Cancer Patients

Popescu, Irinel

doi:10.4183/aeb.2013.419

Cited by 3 publications

(1 citation statement)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In France, for example, 92% of the surveyed general population knew about sun risks and sun protection, 60% knew the ABCDE rule, and 43% of respondents had consulted a doctor at least once for a suspect skin lesion [63]. In contrast, in Romania, 90.76% of all surveyed skin cancer patients were not warned by any doctor about their skin cancer risk and more than 65% of them never had a medical skin check before diagnosis [64].…”

Section: Melanoma Thickness In Europementioning

confidence: 99%

Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities

Forsea

2020

Dermatol Pract Concept

View full text Add to dashboard Cite

Melanoma claims annually more than 20,000 lives in Europe and is an important public health burden through its continuously increasing incidence and with its high mortality, costs, and complexity of care in advanced stages. Epidemiological surveillance is indispensable for the research into its causes, new prognostic markers, and innovative therapies, as well as for the building of efficient cancer control plans. However, important differences in the sources and availability of accurate epidemiological data exist among European countries and regions, contributing to a heterogeneous picture with 20-fold differences in the reported national melanoma incidence rates, divergent mortality trends, and solid disparities in survival across the Continent. Countries in the eastern half of Europe report the lowest incidence rates, but high case fatality, persisting and increasing mortality, a higher proportion of thicker tumors and late diagnosis, and lower survival rates. They are the least well equipped with quality cancer registration and reporting, and they lag behind in efficient cancer control plans implementation. This review highlights the main differences in melanoma epidemiology across Europe, together with an insight into their underlying causes in the areas of melanoma registration, early diagnosis, and prevention. These differences should be acknowledged and understood by physicians, researchers, and all stakeholders involved in improving melanoma care and outcomes, as no one-size-fits-all solution can tackle the melanoma problem in Europe. Instead, there is a need for nuanced strategies, adapted to the heterogeneous national and regional contexts, that would build on European diversity to eliminate the outcome disparities.

show abstract

Section: Melanoma Thickness In Europementioning

confidence: 99%

Melanoma Epidemiology and Early Detection in Europe: Diversity and Disparities

Forsea

2020

Dermatol Pract Concept

View full text Add to dashboard Cite

show abstract

Measures of psychosocial factors that may influence help-seeking behaviour in cancer: A systematic review of psychometric properties

et al. 2017

View full text Add to dashboard Cite

Advanced stage cancer is frequently attributed to delays in presentation to a healthcare professional. To reduce undue delay, it is imperative to understand the reasons underlying help-seeking behaviour and to measure those using valid and reliable tools. This systematic review aimed to identify how studies have measured psychosocial factors affecting time to presentation for (potential) cancer symptoms. A total of 35 studies were included. Most studies failed to use valid and reliable tools, and predominantly provided inconclusive results regarding psychosocial factors and time to presentation when no or minimal psychometric evidence was present. Consequently, measure selection and future measure development should be guided by psychometric principles.

show abstract